NO864269D0 - Fremgangsmaate for fremstilling av en naeringsmiddelemulsjon - Google Patents
Fremgangsmaate for fremstilling av en naeringsmiddelemulsjonInfo
- Publication number
- NO864269D0 NO864269D0 NO864269A NO864269A NO864269D0 NO 864269 D0 NO864269 D0 NO 864269D0 NO 864269 A NO864269 A NO 864269A NO 864269 A NO864269 A NO 864269A NO 864269 D0 NO864269 D0 NO 864269D0
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- procedure
- food emulsion
- emulsion
- food
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8505048A SE8505048L (sv) | 1985-10-25 | 1985-10-25 | Nutritionsemulsion med syretransporterande egenskaper |
Publications (2)
Publication Number | Publication Date |
---|---|
NO864269D0 true NO864269D0 (no) | 1986-10-24 |
NO864269L NO864269L (no) | 1987-04-27 |
Family
ID=20361921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO864269A NO864269L (no) | 1985-10-25 | 1986-10-24 | Fremgangsmaate for fremstilling av en naeringsmiddelemulsjon |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0220153B1 (no) |
DE (1) | DE3680451D1 (no) |
DK (1) | DK510486A (no) |
NO (1) | NO864269L (no) |
SE (1) | SE8505048L (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4931472A (en) * | 1985-09-17 | 1990-06-05 | Biomed Technology, Inc. | Fluorinated triethylenediamine as an oxygen transport agent |
US4987154A (en) * | 1986-01-14 | 1991-01-22 | Alliance Pharmaceutical Corp. | Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
US5077036A (en) * | 1986-01-14 | 1991-12-31 | Alliance Pharmaceutical Corp. | Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid |
US5847009A (en) | 1986-01-14 | 1998-12-08 | Alliance Pharmaceutical Corp. | Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions |
US5284645A (en) * | 1987-08-05 | 1994-02-08 | Alliance Pharmaceutical Corp. | Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems |
US4927623A (en) * | 1986-01-14 | 1990-05-22 | Alliance Pharmaceutical Corp. | Dissolution of gas in a fluorocarbon liquid |
US5684050A (en) * | 1986-01-24 | 1997-11-04 | Hemagen/Pfc | Stable emulsions of highly fluorinated organic compounds |
EP0231091B1 (en) * | 1986-01-24 | 1993-03-31 | Children's Hospital Medical Center | Stable emulsions of highly fluorinated organic compound |
US5514720A (en) * | 1986-07-09 | 1996-05-07 | Hemagen/Pfc | Stable emulsions of highly fluorinated organic compounds |
US4895876A (en) * | 1987-03-20 | 1990-01-23 | Air Products And Chemicals, Inc. | Concentrated stable fluorochemical aqueous emulsions containing triglycerides |
US4866096A (en) * | 1987-03-20 | 1989-09-12 | Air Products And Chemicals, Inc. | Stable fluorochemical aqueous emulsions |
US5171755A (en) * | 1988-04-29 | 1992-12-15 | Hemagen/Pfc | Emulsions of highly fluorinated organic compounds |
US5114703A (en) * | 1989-05-30 | 1992-05-19 | Alliance Pharmaceutical Corp. | Percutaneous lymphography using particulate fluorocarbon emulsions |
JP2644358B2 (ja) * | 1990-03-15 | 1997-08-25 | 帝人株式会社 | 細胞の培養方法 |
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
FR2679788B1 (fr) * | 1991-08-02 | 1994-03-18 | Thorel Jean Noel | Structures d'emulsions polyphasiques autostabilisees. |
US5304325A (en) * | 1991-11-13 | 1994-04-19 | Hemagen/Pfc | Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use |
US5403575A (en) * | 1991-12-12 | 1995-04-04 | Hemagen/Pfc | Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them |
DE4338046A1 (de) * | 1993-11-08 | 1995-05-11 | Dietl Hans | Fettlösliche Arzneimittel erhaltende flüssige pharmazeutische Zubereitung zur oralen Anwendung |
US5733526A (en) * | 1995-12-14 | 1998-03-31 | Alliance Pharmaceutical Corp. | Hydrocarbon oil/fluorochemical preparations and methods of use |
US6447806B1 (en) | 1999-02-25 | 2002-09-10 | Novartis Ag | Pharmaceutical compositions comprised of stabilized peptide particles |
WO2002005870A2 (en) * | 2000-07-19 | 2002-01-24 | Neuron Therapeutics, Inc. | Kits and compositions supporting intracranial perfusions |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1256162A (en) * | 1968-08-16 | 1971-12-08 | Braun Fa B | Improvements in and relating to liquid products for intravenous administration |
JPS537492B2 (no) * | 1973-02-12 | 1978-03-18 | ||
JPS5331209B2 (no) * | 1973-10-05 | 1978-09-01 | ||
US4252827A (en) * | 1979-05-23 | 1981-02-24 | The Green Cross Corporation | Oxygen-transferable fluorocarbon emulsion |
JPS5924132B2 (ja) * | 1980-12-02 | 1984-06-07 | 株式会社 林原生物化学研究所 | 栄養補給用乳剤の製法 |
US4446154A (en) * | 1982-03-03 | 1984-05-01 | Thomas Jefferson University | Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders |
US4423077A (en) * | 1982-07-27 | 1983-12-27 | The University Of Pennsylvania | Perfluorochemical emulsion artificial blood |
-
1985
- 1985-10-25 SE SE8505048A patent/SE8505048L/ not_active Application Discontinuation
-
1986
- 1986-10-23 EP EP86850373A patent/EP0220153B1/en not_active Expired - Lifetime
- 1986-10-23 DE DE8686850373T patent/DE3680451D1/de not_active Expired - Fee Related
- 1986-10-24 NO NO864269A patent/NO864269L/no unknown
- 1986-10-24 DK DK510486A patent/DK510486A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK510486D0 (da) | 1986-10-24 |
EP0220153B1 (en) | 1991-07-24 |
SE8505048L (sv) | 1987-04-26 |
EP0220153A1 (en) | 1987-04-29 |
NO864269L (no) | 1987-04-27 |
DK510486A (da) | 1987-04-26 |
SE8505048D0 (sv) | 1985-10-25 |
DE3680451D1 (de) | 1991-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO864269L (no) | Fremgangsmaate for fremstilling av en naeringsmiddelemulsjon | |
NO157302C (no) | Fremgangsmaate for fremstilling av et fiskeoljekonsentrat. | |
ES554380A0 (es) | Un procedimiento para preparar derivados de 8-fenilxantina | |
ES554433A0 (es) | Procedimiento de prepracion de productos grageados | |
ES554567A0 (es) | Un procedimiento para preparar derivados de 8-amino-purina | |
NO173213C (no) | Fremgangsmaate for fremstilling av et preparat omfattende et liposom | |
NO167034C (no) | Fremgangsmaate for fremstilling av 1,6-diklor-1,6-dideoksy-beta-d-fruktofuranosyl-4-kloro-4-dioksy-alfa-galactopyranosid | |
NO861114L (no) | Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater. | |
NO863608D0 (no) | Fremgangsmaate for fremstilling av benzimidazolderivater. | |
ES556026A0 (es) | Un procedimiento para preparar derivados de tienopiridona | |
NO864697D0 (no) | Fremgangsmaate for fremstilling av krydder. | |
NO862860L (no) | Fremgangsmaate for fremstilling av poly-4-aminopyrrole-2-karboksamidoderivater. | |
ES550819A0 (es) | Un procedimiento para preparar nuevos derivados de cefem. | |
NO863634D0 (no) | Fremgangsmaate for fremstilling av hoeyren koks. | |
ES557397A0 (es) | Un procedimiento para preparar derivados arilicos de diemanidas. | |
ES552617A0 (es) | Un procedimiento para preparar derivados de bencimidazol | |
ES554238A0 (es) | Un precedimiento para preparar derivados de ciclopentil-eter | |
KR870001175A (ko) | 5-치환된-6-아미노피리미딘 유도체의 제조방법 | |
ES553814A0 (es) | Un procedimiento para preparar nuevos derivados de aminocetona | |
DK161662C (da) | Underlagsbrik for et kogekar | |
KR870002119A (ko) | 메틸렌디옥시페난트렌 및 스틸벤유도체의 제조방법 | |
ES555384A0 (es) | Procedimiento de preparar diosmina | |
AR241134A1 (es) | Un procedimiento para preparar w-lactamas | |
ES557568A0 (es) | Un procedimiento para preparar etil-alfa-(1-carboxi-etil)-ami-no-gamma-fenilbutirato | |
IT8519530A0 (it) | Procedimento per preparare fluoroderivati alchilici |